Project documents | Talazoparib with enzalutamide for untreated hormone-relapsed metastatic prostate cancer [ID4004] | Guidance | NICE

Documents

Documents created during the development process.

Invitation to participate

Equality impact assessment (scoping) (PDF 142 KB)

Published:

15 July 2024
Final scope (PDF 243 KB)

Published:

15 July 2024
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 275 KB)

Published:

15 July 2024
Final stakeholder list (PDF 184 KB)

Published:

15 July 2024

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 186 KB)

Published:

17 June 2024
Draft matrix post referral (PDF 133 KB)

Published:

17 June 2024

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft matrix post referral (PDF 163 KB)

Published:

02 September 2022
Draft scope post referral (PDF 227 KB)

Published:

02 September 2022